An integrated LC-HRMS workflow for anti-doping-relevant characterization of lapisteride metabolism in vivo and in vitro
The Analyst · 2026
DOI: 10.1039/d6an00634e ↗Kurz gefasst
Fachartikel in der Zeitschrift The Analyst, 2026. Verfasst von Zhongquan Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Doping Control, Shanghai University of Sport, Shanghai 200438, China. liubing2019@sus.edu.cn. Hauptthemen laut MEDLINE: Doping in Sports. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Lapisteride is a 4-azasteroid 5α-reductase inhibitor with unclear metabolism. This study characterizes its metabolic profile and offers a strategy for investigating compounds with limited metabolic data when human studies are not feasible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Institute for Doping Control, Shanghai University of Sport, Shanghai 200438, China. liubing2019@sus.edu.cn.
- School of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China.
Zitieren
APA
Li, Z., Liu, B., & Chen, P. (2026). An integrated LC-HRMS workflow for anti-doping-relevant characterization of lapisteride metabolism in vivo and in vitro. The Analyst. https://doi.org/10.1039/d6an00634e
Vancouver
Li Z, Liu B, Chen P. An integrated LC-HRMS workflow for anti-doping-relevant characterization of lapisteride metabolism in vivo and in vitro. The Analyst. 2026. doi:10.1039/d6an00634e
BibTeX
@article{Li2026,
author = {Li, Zhongquan and Liu, Bing and Chen, Peijie},
title = {An integrated LC-HRMS workflow for anti-doping-relevant characterization of lapisteride metabolism in vivo and in vitro},
journal = {The Analyst},
year = {2026},
doi = {10.1039/d6an00634e}
}
EUVIMED